OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 1404 citing articles:

Bipolar disorders
Roger S. McIntyre, Michael Berk, Elisa Brietzke, et al.
The Lancet (2020) Vol. 396, Iss. 10265, pp. 1841-1856
Closed Access | Times Cited: 678

Bipolar disorders
Eduard Vieta, Michael Berk, Thomas G. Schulze, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 648

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Gin S. Malhi, Erica Bell, Darryl Bassett, et al.
Australian & New Zealand Journal of Psychiatry (2020) Vol. 55, Iss. 1, pp. 7-117
Closed Access | Times Cited: 395

Time for united action on depression: a Lancet–World Psychiatric Association Commission
Helen Herrman, Vikram Patel, Christian Kieling, et al.
The Lancet (2022) Vol. 399, Iss. 10328, pp. 957-1022
Open Access | Times Cited: 284

Cardiovascular disease in patients with severe mental illness
René Ernst Nielsen, Jytte Banner, Svend Eggert Jensen
Nature Reviews Cardiology (2020) Vol. 18, Iss. 2, pp. 136-145
Closed Access | Times Cited: 267

Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Maija Dambrova, Marina Makrecka-Kūka, Janis Kuka, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 506-551
Open Access | Times Cited: 265

Suicide Risk in Bipolar Disorder: A Brief Review
Péter Döme, Zoltán Rihmer, Xénia Gonda
Medicina (2019) Vol. 55, Iss. 8, pp. 403-403
Open Access | Times Cited: 222

Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data
Stephen M. Stahl, Sarah Laredo, Debbi Ann Morrissette
Therapeutic Advances in Psychopharmacology (2020) Vol. 10, pp. 204512532090575-204512532090575
Open Access | Times Cited: 217

The identification, assessment and management of difficult-to-treat depression: An international consensus statement
R. Hamish McAllister‐Williams, Celso Arango, Pierre Blier, et al.
Journal of Affective Disorders (2020) Vol. 267, pp. 264-282
Open Access | Times Cited: 192

When to consider electroconvulsive therapy (ECT)
Charles H. Kellner, Jasmien Obbels, Pascal Sienaert
Acta Psychiatrica Scandinavica (2019) Vol. 141, Iss. 4, pp. 304-315
Closed Access | Times Cited: 182

Adjunctive Psychotherapy for Bipolar Disorder
David J. Miklowitz, Orestis Efthimiou, Toshi A. Furukawa, et al.
JAMA Psychiatry (2020) Vol. 78, Iss. 2, pp. 141-141
Open Access | Times Cited: 181

Bipolar depression: a major unsolved challenge
Ross J. Baldessarini, Gustavo Vázquez, Leonardo Tondo
International Journal of Bipolar Disorders (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 179

The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology
John F. Gottlieb, Francesco Benedetti, Pierre A. Geoffroy, et al.
Bipolar Disorders (2019) Vol. 21, Iss. 8, pp. 741-773
Open Access | Times Cited: 165

Clinical use of lithium salts: guide for users and prescribers
Leonardo Tondo, Martin Alda, Michael Bauer, et al.
International Journal of Bipolar Disorders (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 161

Bipolar depression: the clinical characteristics and unmet needs of a complex disorder
Roger S. McIntyre, Joseph R. Calabrese
Current Medical Research and Opinion (2019) Vol. 35, Iss. 11, pp. 1993-2005
Open Access | Times Cited: 154

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial
M. Ishrat Husain, Imran B. Chaudhry, Ameer B. Khoso, et al.
The Lancet Psychiatry (2020) Vol. 7, Iss. 6, pp. 515-527
Open Access | Times Cited: 139

Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial
Mocrane Abbar, Christophe Dematteï, Wissam El‐Hage, et al.
BMJ (2022), pp. e067194-e067194
Open Access | Times Cited: 119

The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management
Roger S. McIntyre, Martin Alda, Ross J. Baldessarini, et al.
World Psychiatry (2022) Vol. 21, Iss. 3, pp. 364-387
Open Access | Times Cited: 105

Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities
Miguel Á. Ortega, Miguel Ángel Alvarez-Mon, Cielo García‐Montero, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2645-2673
Open Access | Times Cited: 70

Diagnosis and management of bipolar disorders
Fernando S. Goes
BMJ (2023), pp. e073591-e073591
Open Access | Times Cited: 63

Psychotropic Drug–Related Weight Gain and Its Treatment
Roger S. McIntyre, Angela T.H. Kwan, Joshua D. Rosenblat, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 26-38
Closed Access | Times Cited: 44

Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis
Ayşegül Yıldız, Spyridon Siafis, Dimitris Mavridis, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 9, pp. 693-705
Open Access | Times Cited: 42

Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis
Vincenzo Oliva, Chiara Possidente, Michele De Prisco, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 3, pp. 210-220
Open Access | Times Cited: 20

Page 1 - Next Page

Scroll to top